Blocking the “95% Virus”: The 2026 Breakthrough in EBV Research
Scientists at the Fred Hutchinson Cancer Center reached a historic milestone in February 2026 by developing a first-of-its-kind antibody that successfully blocks the Epstein-Barr Virus (EBV). EBV is one of … Read More